Clozapine
Class
Tricylic dibenzodiazepine atypical antipsychotic
Indications
Treatment resistant schizophrenia
Administration/Absorption
Oral
Dosage
Distribution
97% protein bound
Mechanism
Selective monoaminergic antagonist with high affinity for:
serotonin Type 2 (5HT2)
dopamine Type 2 (D2)
Clozapine acts as an antagonist at other receptors, but with lower potency, explaining side effects
Antagonism of histamine H1 receptors may explain somnolence
Antagonism of adrenergic a1 receptors may explain orthostatic hypotension
Antipsychotic action is likely mediated through a combination of antogistic effects at:
D2 receptors in the mesolimbic pathway
Relieves positive symptoms
5-HT2A receptors in the frontal cortex
Alleviates negative symptoms.
Excretion
Half-life 8 hours (range 4-12 hours)
Approximately 50% of the administered dose is excreted in the urine and 30% in the feces
Side effects
Serious
monitoring by frequent FBC
other adverse cardiovascular and respiratory effects
increased mortality in elderly patients with dementia-related psychosis
weight gain
GI hypomotility
sialorrhoea
Interactions
Fluvoxamine inhibits the metabolism of clozapine leading to significantly increased blood levels of clozapine
Alcohol
Caffeine
Contraindications
uncontrolled epilepsy
agranulocytosis with prior clozapine treatment